We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.38B
1-Year Est. Return 63.08%
This Fund
S&P 500
This Quarter Est. Return
+13.06%
1 Year Est. Return
+63.08%
3 Year Est. Return
+180.99%
5 Year Est. Return
+483.22%
10 Year Est. Return
+2,128.62%
AUM
$4.23B
AUM Growth
+$208M
Cap. Flow
+$191M
Cap. Flow %
4.51%
Top 10 Hldgs %
66.8%
Holding
503
New
83
Increased
81
Reduced
97
Closed
181

Top Buys

Rank Stock Value
1
ITCI
Intra-Cellular Therapies Inc.
ITCI
+$383M
2
DFS
Discover Financial Services
DFS
+$224M
3
BECN
Beacon Roofing Supply, Inc.
BECN
+$183M
4
WBA
Walgreens Boots Alliance
WBA
+$110M
5
JWN
Nordstrom
JWN
+$95.8M

Top Sells

Rank Stock Value
1
HCP
HashiCorp, Inc. Class A Common Stock
HCP
+$235M
2
SMAR
Smartsheet Inc.
SMAR
+$216M
3
EDR
Endeavor Group Holdings, Inc.
EDR
+$144M
4
SUM
Summit Materials, Inc. Class A Common Stock
SUM
+$103M
5
ALTR
Altair Engineering Inc
ALTR
+$97.9M

Sector Composition

Rank Sector Weight
1 Energy 17.21%
2 Healthcare 16.93%
3 Financials 12.93%
4 Industrials 12.5%
5 Technology 10.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BAX icon
126
Baxter International
BAX
$14B
$1.85M 0.04%
54,155
+20,551
+61% +$672K
KIDS icon
127
OrthoPediatrics
KIDS
$596M
$1.84M 0.04%
74,862
+9,570
+15% +$236K
GOOGL icon
128
Alphabet (Google) Class A
GOOGL
$4.38T
$1.84M 0.04%
+11,900
New +$2.16M
MSFT icon
129
Microsoft
MSFT
$3.71T
$1.8M 0.04%
4,794
-20,050
-81% -$8.17M
TSLA icon
130
PUT
Tesla
TSLA
$1.26T
$1.76M 0.04%
12,500
+2,000
+19% +$667K
AGIO icon
131
Agios Pharmaceuticals
AGIO
$1.91B
$1.72M 0.04%
58,722
+15,392
+36% +$511K
SWTX
132
DELISTED
SpringWorks Therapeutics
SWTX
$1.72M 0.04%
38,968
-2,525
-6% -$116K
STRK
133
Strategy Inc 8.00% Series A Perpetual Strike Preferred Stock
STRK
$476M
$1.68M 0.04%
+20,000
New +$1.79M
TLT icon
134
CALL
iShares 20+ Year Treasury Bond ETF
TLT
$41.6B
$1.68M 0.04%
+1,650,000
New +$147M
PRCT icon
135
Procept Biorobotics
PRCT
$1.15B
$1.63M 0.04%
+28,000
New +$1.91M
AXGN icon
136
Axogen
AXGN
$2.38B
$1.62M 0.04%
87,428
-53,000
-38% -$956K
CLBR
137
DELISTED
Colombier Acquisition Corp II
CLBR
$1.6M 0.04%
150,000
-41,738
-22% -$451K
TEVA icon
138
Teva Pharmaceuticals
TEVA
$40.6B
$1.55M 0.04%
100,788
-37,237
-27% -$665K
BAP icon
139
Credicorp
BAP
$31.2B
$1.55M 0.04%
8,311
– –
POLE
140
Andretti Acquisition Corp II
POLE
$319M
$1.52M 0.04%
150,000
– –
RZLT icon
141
Rezolute
RZLT
$453M
$1.46M 0.03%
502,908
-23,315
-4% -$102K
OFIX icon
142
Orthofix Medical
OFIX
$432M
$1.45M 0.03%
89,059
-8,402
-9% -$147K
VRDN icon
143
Viridian Therapeutics
VRDN
$2.55B
$1.44M 0.03%
107,088
+62,488
+140% +$1.06M
ALGN icon
144
Align Technology
ALGN
$12B
$1.44M 0.03%
9,050
+1,800
+25% +$353K
IRTC icon
145
iRhythm Holdings
IRTC
$4.21B
$1.41M 0.03%
13,506
-5,685
-30% -$602K
GMAB icon
146
Genmab
GMAB
$18.3B
$1.41M 0.03%
+71,877
New +$1.51M
ADPT icon
147
Adaptive Biotechnologies
ADPT
$3.75B
$1.4M 0.03%
187,789
-26,040
-12% -$200K
KDK
148
Kodiak AI
KDK
$842M
$1.39M 0.03%
125,000
-40,422
-24% -$447K
CRNX icon
149
Crinetics Pharmaceuticals
CRNX
$8.9B
$1.36M 0.03%
40,613
+12,926
+47% +$483K
PVLA
150
Palvella Therapeutics
PVLA
$2.23B
$1.36M 0.03%
+48,664
New +$938K
4 5
6
7 8

Similar funds

FNBT
FineMark National Bank & Trust Fort Myers, Florida $3.2B AUM 18.28% 1-Year Est. Return
SAG
SageView Advisory Group Newport Beach, California $2.96B AUM 15.81% 1-Year Est. Return
ACI
Alpha Cubed Investments Irvine, California $2.92B AUM 31.27% 1-Year Est. Return
TCOV
Trust Company of Vermont Brattleboro, Vermont $2.4B AUM 18.8% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
A
AlphaQuest New York $1.79B AUM 10.61% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
CB
Cadence Bank Tupelo, Mississippi $1.71B AUM 16.17% 1-Year Est. Return

UBS O'Connor's Q1 2025 Portfolio in Review

As of Q1 2025, UBS O'Connor held 503 positions worth $4.23B, up 5.2% from $4.02B the previous quarter. Its ten largest holdings account for 67% of the portfolio.

UBS O'Connor deployed $191M of net new capital in Q1 2025, opening 83 new positions and adding to 81 existing holdings. Its largest new stake was Beacon Roofing Supply, Inc.: 1,575,016 shares worth $195M.

By sector, the portfolio is most concentrated in Energy at 17% of assets, up from 16% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Juniper Networks, an estimated $71.4M trimmed.

  • UBS O'Connor's largest Q1 2025 buy was Beacon Roofing Supply, Inc.: 1,575,016 shares worth $195M.
  • UBS O'Connor added most to Intra-Cellular Therapies Inc. in Q1 2025, an estimated $383M increase.
  • UBS O'Connor's biggest Q1 2025 reduction was Juniper Networks, cutting an estimated $71.4M.
  • UBS O'Connor fully exited HashiCorp, Inc. Class A Common Stock in Q1 2025, selling an estimated $235M.
  • UBS O'Connor's ten largest holdings make up 67% of its $4.23B portfolio in Q1 2025.
  • UBS O'Connor opened 83 new positions and closed 181 in Q1 2025.
  • UBS O'Connor's portfolio value rose 5.2% quarter-over-quarter to $4.23B.

Based on UBS O'Connor's 13F filing for Q1 2025, filed 15 May 2025.